Moolec Science MLECW
NASDAQ MLECW
$0.02 +0.00 (+2.56%)
As of: Aug 19, 2026 · 2:06 PM EDT

Moolec Science (MLECW) Accumulated Expenses (2022 - 2025)

Moolec Science (MLECW) posted Accumulated Expenses of $129468.0 for Q4 2025, down 46.86% sequentially from $243634.0 in Q2 2025, and up 87.38% YoY from $69095.0 in Q4 2024.

Moolec Science (MLECW) Accumulated Expenses (2022 - 2025) Analysis & Trends

Moolec Science has reported Accumulated Expenses for 4 years, with the latest figure at $129468.0 in Q4 2025.

  • Quarterly Accumulated Expenses rose 87.38% year-over-year to $129468.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $129468.0 (up 87.38% YoY) and the FY2025 annual result came in at $243634.0, down 96.75% from the prior year.
  • Accumulated Expenses retreated to $129468.0 in Q4 2025 per MLECW's latest filing, from $243634.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $10.0 million in Q2 2023 and troughed at $69095.0 in Q4 2024.
  • A 4-year average of $3.7 million and a median of $2.2 million in 2022 frame the typical range for Accumulated Expenses.
  • The sharpest annual moves came in 2023 and 2025: Accumulated Expenses soared 1948.62% in 2023, then slumped 96.75% in 2025.
  • Over 4 years, Accumulated Expenses stood at $7.5 million in 2022, then jumped by 32.66% to $10.0 million in 2023, then slumped by 99.31% to $69095.0 in 2024, then surged by 87.38% to $129468.0 in 2025.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $129468.0, $243634.0, and $69095.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Moolec Science 8,617.72 -1.19 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 129,468.00
Jun 30, 2025 243,634.00
Dec 31, 2024 69,095.00
Jun 30, 2024 7.51 Mn
Jun 30, 2023 9.95 Mn
Mar 31, 2023 3.99 Mn
Dec 31, 2022 7.50 Mn
Jun 30, 2022 485,735.00